SG10201501780QA - Method of purifying influenza virus and removing mdck cell dna contaminants - Google Patents

Method of purifying influenza virus and removing mdck cell dna contaminants

Info

Publication number
SG10201501780QA
SG10201501780QA SG10201501780QA SG10201501780QA SG10201501780QA SG 10201501780Q A SG10201501780Q A SG 10201501780QA SG 10201501780Q A SG10201501780Q A SG 10201501780QA SG 10201501780Q A SG10201501780Q A SG 10201501780QA SG 10201501780Q A SG10201501780Q A SG 10201501780QA
Authority
SG
Singapore
Prior art keywords
influenza virus
cell dna
mdck cell
dna contaminants
purifying influenza
Prior art date
Application number
SG10201501780QA
Inventor
Jonathan Liu
Richard Schwartz
Mark Thompson
Luis Maranga
Simon Hsu
Mridul Ghosh
Ajit Subramanian
Original Assignee
Medimmune Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Llc filed Critical Medimmune Llc
Publication of SG10201501780QA publication Critical patent/SG10201501780QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C12N2760/16152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251—Methods of production or purification of viral material
    • C12N2760/16252—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
SG10201501780QA 2006-09-15 2007-09-14 Method of purifying influenza virus and removing mdck cell dna contaminants SG10201501780QA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84512106P 2006-09-15 2006-09-15
US87172106P 2006-12-22 2006-12-22
US91700807P 2007-05-09 2007-05-09
US95181307P 2007-07-25 2007-07-25

Publications (1)

Publication Number Publication Date
SG10201501780QA true SG10201501780QA (en) 2015-04-29

Family

ID=39721761

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201501780QA SG10201501780QA (en) 2006-09-15 2007-09-14 Method of purifying influenza virus and removing mdck cell dna contaminants
SG2011066164A SG174813A1 (en) 2006-09-15 2007-09-14 Mdck cell lines supporting viral growth to high titers and bioreactor process using the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2011066164A SG174813A1 (en) 2006-09-15 2007-09-14 Mdck cell lines supporting viral growth to high titers and bioreactor process using the same

Country Status (13)

Country Link
US (3) US20080286850A1 (en)
EP (2) EP2615167A1 (en)
JP (2) JP5260525B2 (en)
KR (2) KR20140075022A (en)
CN (2) CN103361319A (en)
AU (1) AU2007347716B2 (en)
BR (1) BRPI0716724A2 (en)
CA (1) CA2663522C (en)
ES (1) ES2473275T3 (en)
MX (1) MX2009002741A (en)
RU (2) RU2487935C2 (en)
SG (2) SG10201501780QA (en)
WO (1) WO2008105931A2 (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101260084B1 (en) * 2004-12-23 2013-05-03 메디뮨 엘엘씨 Non-tumorigenic mdck cell line for propagating viruses
CN101472941B (en) 2006-03-31 2017-08-08 沃弗-威斯康星校友研究基金会 High titer recombinant influenza viruses for vaccine
US20080286850A1 (en) 2006-09-15 2008-11-20 Medimmune Vaccines, Inc. Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
WO2008156778A2 (en) 2007-06-18 2008-12-24 Tokiko Watanabe Influenza m2 protein mutant viruses as live influenza attenuated vaccines
KR20110074563A (en) 2008-09-24 2011-06-30 메디뮨 엘엘씨 Methods for purification of viruses
AU2009296701B2 (en) * 2008-09-24 2015-02-19 Medimmune, Llc Methods for cultivating cells, propagating and purifying viruses
WO2010052214A2 (en) * 2008-11-05 2010-05-14 Glaxosmithkline Biologicals S.A. Novel method
JP2010143860A (en) * 2008-12-19 2010-07-01 Chisso Corp Protein stabilizer
US9109013B2 (en) 2009-10-26 2015-08-18 Wisconsin Alumni Research Foundation High titer recombinant influenza viruses with enhanced replication in vero cells
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
US20110262965A1 (en) * 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
WO2011135393A1 (en) * 2010-04-27 2011-11-03 Universidad Manuela Beltran Autologous biological cancer vaccine
AR080972A1 (en) * 2010-04-28 2012-05-23 Abbott Biologicals Bv PRODUCTION OF VIRAL COMPONENTS
TW201211257A (en) * 2010-08-16 2012-03-16 Cevec Pharmaceuticals Gmbh Permanent human cell line for influenza virus preparation
CN101979517B (en) * 2010-10-15 2011-12-28 普莱柯生物工程股份有限公司 Method for producing influenza viruses in large scale by using bioreactor
EP3246400B1 (en) 2012-01-09 2019-10-23 Sanofi Pasteur Biologics, LLC Purification of herpes virus
CN102526720B (en) * 2012-01-11 2013-12-11 中国人民解放军军事医学科学院微生物流行病研究所 Preparation method of influenza virus vaccine
JP6152535B2 (en) * 2012-04-16 2017-06-28 公益財団法人ヒューマンサイエンス振興財団 Cell culture composition and method for producing influenza virus
US11260123B2 (en) 2012-05-21 2022-03-01 Sanofi Pasteur Limited Herpesvirus compositions and related methods
RU2506310C1 (en) * 2012-07-23 2014-02-10 Государственное научное учреждение Всероссийский научно-исследовательский институт ветеринарной вирусологии и микробиологии Россельхозакадемии STRAIN OF DIPLOID CELLS OF SYNOVIAL MEMBRANE OF YOUNG PIG Sus scrofa, USED FOR VIROLOGY RESEARCH
RU2507255C1 (en) * 2012-07-23 2014-02-20 Государственное научное учреждение Всероссийский научно-исследовательский институт ветеринарной вирусологии и микробиологии Россельхозакадемии STRAIN OF DIPLOID CELLS OF LAMB SYNOVIAL MEMBRANE Ovis aries USED FOR VIROLOGICAL INVESTIGATIONS
EA038206B1 (en) 2012-12-28 2021-07-23 Бёрингер Ингельхайм Ветмедика Гмбх Immunogenic composition comprising mycoplasma antigens
MX361273B (en) 2012-12-28 2018-12-03 Boehringer Ingelheim Vetmedica Gmbh Method of making a mycoplasma vaccine.
KR101370512B1 (en) 2013-06-07 2014-03-06 재단법인 목암생명공학연구소 Mdck-derived cell lines suspension-cultured in a protein-free medium and method for propagating virus using the same
EP3022296B1 (en) 2013-07-15 2022-12-28 Wisconsin Alumni Research Foundation High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs
JP2014088409A (en) * 2013-12-20 2014-05-15 Jnc Corp Protein stabilizer
WO2015196150A2 (en) 2014-06-20 2015-12-23 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
CN104212768A (en) * 2014-09-18 2014-12-17 中国科学院大连化学物理研究所 Protein-free culture medium for culturing microencapsulated recombinant Chinese hamster ovary (CHO) cells and preparation method thereof
WO2016083560A1 (en) * 2014-11-28 2016-06-02 Uniqure Ip B.V. Dna impurities in a composition comprising a parvoviral virion
RU2573938C1 (en) * 2014-12-11 2016-01-27 Федеральное государственное бюджетное учреждение науки Институт биологии гена Российской академии наук Cell line of human kidney cancer ibgvat r 27
RU2573940C1 (en) * 2014-12-11 2016-01-27 Федеральное государственное бюджетное учреждение науки Институт биологии гена Российской академии наук Cell line of human kidney cancer ibgvat r 6
CN104689311A (en) * 2014-12-31 2015-06-10 瑞普（保定）生物药业有限公司 Method for producing avian encephalomyelitis virus inactivated vaccine
WO2016148195A1 (en) * 2015-03-17 2016-09-22 一般財団法人阪大微生物病研究会 Cells for influenza virus production
US10633422B2 (en) 2015-06-01 2020-04-28 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
WO2017007839A1 (en) 2015-07-06 2017-01-12 Wisconsin Alumni Research Foundation (Warf) Improved influenza virus replication for vaccine development
CN105349499B (en) * 2015-11-06 2018-12-07 张澍 A kind of preparation method of bird flu whole virus particles marker vaccine and products thereof and purposes
JP2019510481A (en) 2016-02-19 2019-04-18 ウィスコンシン アルムニ リサーチ ファンデイション Improved influenza B virus replication for vaccine development
AU2017244758B2 (en) * 2016-03-29 2022-08-25 The Research Foundation For Microbial Diseases Of Osaka University Method for culturing MDCK cells
CN106119186B (en) * 2016-06-24 2019-10-08 肇庆大华农生物药品有限公司 It is a kind of for the serum free medium and preparation method thereof for cultivating mdck cell that suspends entirely
EP3299454A1 (en) * 2016-09-21 2018-03-28 Deutsches Krebsforschungszentrum Optimized method for large scale production of parvovirus h-1 in an essentially serum-free medium
CN106520700B (en) * 2016-11-10 2019-12-27 中国食品药品检定研究院 MDCK cell line for stably expressing bovine trypsinogen and application thereof
WO2020167432A2 (en) 2019-01-23 2020-08-20 Yoshihiro Kawaoka Mutations that confer genetic stability to additional genes in influenza viruses
WO2020163804A1 (en) 2019-02-08 2020-08-13 Wisconsin Alumni Research Foundation (Warf) Humanized cell line
US11390649B2 (en) 2019-05-01 2022-07-19 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication for vaccine development
JP2022551805A (en) 2019-08-27 2022-12-14 ウィスコンシン アルムニ リサーチ ファンデイション Recombinant Influenza Virus with Stabilized HA for Intraovo Replication
CN115315518A (en) * 2020-01-17 2022-11-08 阿斯克肋匹奥生物制药公司 Production of recombinant AAV
WO2021221338A1 (en) 2020-04-29 2021-11-04 에스케이바이오사이언스(주) Influenza virus production method using disposable culture process system, and test for quickly checking conditions for influenza virus antigen purification
KR102444684B1 (en) * 2020-04-29 2022-09-16 에스케이바이오사이언스(주) Method for producing influenza virus using single-use cultivation process system
WO2022066934A2 (en) * 2020-09-23 2022-03-31 Codiak Biosciences, Inc. Process for preparing extracellular vesicles

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO162160C (en) 1987-01-09 1989-11-15 Medi Cult As SERUM-FREE GROWTH MEDIUM AND USE THEREOF.
US5118513A (en) 1987-07-02 1992-06-02 The Procter & Gamble Company Method for enhancing bioavailability of iron-calcium mineral supplements
US6001634A (en) 1989-08-28 1999-12-14 Palese; Peter Recombinant negative strand RNA viruses
US5854037A (en) 1989-08-28 1998-12-29 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand RNA virus expression systems and vaccines
US5166057A (en) 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
US20060019350A1 (en) 1989-08-28 2006-01-26 Peter Palese Recombinant negative strand RNA virus expression system and vacccines
US5786199A (en) 1989-08-28 1998-07-28 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand RNA virus expression systems and vaccines
US5840520A (en) 1989-08-28 1998-11-24 Aviron Recombinant negative strand RNA virus expression systems
SU1698288A1 (en) 1990-02-01 1991-12-15 Всесоюзный научно-исследовательский институт гриппа Strain of virus influenza a/leningrad/325/88 for preparation of influenzal diagnosticum
US6887699B1 (en) 1990-05-22 2005-05-03 Medimmune Vaccines, Inc. Recombinant negative strand RNA virus expression systems and vaccines
US6245549B1 (en) * 1990-06-28 2001-06-12 Connaught Laboratories Limited Production of virus and purification of viral envelope proteins for vaccine use
GB9215834D0 (en) 1992-07-24 1992-09-09 Celltech Ltd Cell culture
US5824536A (en) 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
US5690937A (en) 1995-06-05 1997-11-25 Aviron Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
DE19612966B4 (en) * 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK cells and methods of propagating influenza viruses
DE19612967A1 (en) 1996-04-01 1997-10-02 Behringwerke Ag Process for the propagation of influenza viruses in cell culture, and the influenza viruses obtainable by the process
JP2000517188A (en) 1996-08-30 2000-12-26 ライフ テクノロジーズ，インコーポレイテッド Serum-free mammalian cell culture medium and uses thereof
US20040171152A1 (en) 1996-10-10 2004-09-02 Invitrogen Corporation Animal cell culture media comprising non-animal or plant-derived nutrients
EP1760151B1 (en) * 1996-11-20 2012-03-21 Crucell Holland B.V. Adenovirus compositions obtainable by an improved production and purification method
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
US6884414B1 (en) 1997-04-30 2005-04-26 Mount Sinai School Of Medicine Of New York University Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
US6544785B1 (en) 1998-09-14 2003-04-08 Mount Sinai School Of Medicine Of New York University Helper-free rescue of recombinant negative strand RNA viruses
US8715940B2 (en) * 1999-04-06 2014-05-06 Wisconsin Alumni Research Foundation Method of making recombinant influenza virus
WO2003048348A2 (en) 2001-12-07 2003-06-12 Crucell Holland B.V. Production of viruses, viral isolates and vaccines
DE60037819T2 (en) 1999-08-27 2009-01-08 Invitrogen Corp., Carlsbad METAL BINDING COMPOUNDS AND THEIR USE IN COMPOSITIONS FOR CELL CULTURE MEDIA
KR100797547B1 (en) 2000-03-03 2008-01-24 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
EP2085468A1 (en) 2000-04-28 2009-08-05 St. Jude Children's Research Hospital DNA transfection system for the generation of infectious influenza virus
CN1194005C (en) * 2000-06-01 2005-03-23 长春长生生物科技股份有限公司 Producing influenza killed vaccine by Sepharose 4FF column chromatography technology
EP1297110B1 (en) * 2000-06-23 2009-07-22 Intervet International BV Attenuated bovine respiratory syncytial virus
US20040241139A1 (en) 2000-07-20 2004-12-02 Gerd Hobom Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement
US6593123B1 (en) * 2000-08-07 2003-07-15 Avigen, Inc. Large-scale recombinant adeno-associated virus (rAAV) production and purification
DE10144906B4 (en) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Process for the large-scale production of vaccines
DE10144903A1 (en) 2001-09-12 2003-03-27 Chiron Behring Gmbh & Co Replication of virus in cell cultures, useful for preparing vaccines and diagnostic reagents, where replication of cells and virus is simultaneous
US6951752B2 (en) 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
CA2477037C (en) 2002-02-21 2014-12-09 Mount Sinai School Of Medicine Recombinant negative strand virus rna expression systems and vaccines
WO2003086443A1 (en) 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Spray freeze dry of compositions for intranasal administration
US7465456B2 (en) 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
CN1678345A (en) 2002-04-26 2005-10-05 米迪缪尼疫苗股份有限公司 Multi plasmid system for the production of influenza virus
AU2003249990B2 (en) * 2002-07-09 2007-06-28 Takeda Pharmaceutical Company Limited Animal protein free media for cultivation of cells
EP1585964A4 (en) 2002-08-28 2008-07-16 Introgen Therapeutics Inc Chromatographic methods for adenovirus purification
US20060002862A1 (en) * 2002-12-17 2006-01-05 Medimmune Vaccines, Inc. High pressure spray-dry of bioactive materials
CA2517181C (en) 2003-02-25 2013-07-16 Medimmune Vaccines, Inc. Methods of producing influenza vaccine compositions
WO2004083397A2 (en) * 2003-03-18 2004-09-30 Wyeth Holdings Corporation Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv
US7405068B2 (en) * 2003-05-02 2008-07-29 Tate & Lyle Ingredients Americas, Inc. Pyruvate producing yeast strain
CN1829799A (en) 2003-05-28 2006-09-06 威斯康星旧生研究基金会 Recombinant influenza vectors with a POLII promoter and ribozymes
WO2004110484A1 (en) 2003-06-18 2004-12-23 Gosudarstvenny Nauchny Tsentr Virusologii I Biotekhnologii 'vektor' Method for producing a live tissue-cultural vaccine against influenza virus
WO2005010849A1 (en) 2003-07-31 2005-02-03 Louis Auer Cardiovascular disorder simulation device
JPWO2005026333A1 (en) 2003-09-09 2006-11-16 独立行政法人科学技術振興機構 Suspension culture technique of adherent cells using protease and method for producing virus using the cells as a host
DE602004027537D1 (en) 2003-12-23 2010-07-15 Medimmune Inc
DE602005002829T2 (en) * 2004-03-01 2008-07-10 Ares Trading S.A. USE OF A SERUM-FREE CELL CULTURE MEDIUM FOR THE PRODUCTION OF IL-18BP IN MAMMALIAN CELLS
US8221969B2 (en) 2004-04-19 2012-07-17 Sanyo Chemical Industries, Ltd. Method of producing virus
MXPA06011837A (en) 2004-04-27 2007-01-16 Baxter Int Stirred-tank reactor system.
NZ551640A (en) 2004-05-20 2010-05-28 Id Biomedical Corp Process for the production of an influenza vaccine
JP4629385B2 (en) * 2004-08-16 2011-02-09 Ｎｔｎ株式会社 Needle roller bearing
EP2769735B1 (en) 2004-10-06 2017-04-19 MedImmune, LLC Refrigerator-temperature stable influenza vaccine compositions
AU2005314138B2 (en) 2004-12-08 2011-11-17 Medimmune, Llc Methods of producing influenza vaccine compositions
KR101260084B1 (en) 2004-12-23 2013-05-03 메디뮨 엘엘씨 Non-tumorigenic mdck cell line for propagating viruses
US7910366B2 (en) 2005-03-10 2011-03-22 Kyoritsu Seiyaku Corporation Cell strain capable of being cultured without ingredients derived from animals, method of producing the same, method of producing virus using the same, and method of producing vaccine
US7534596B2 (en) * 2006-02-10 2009-05-19 Solohill Engineering, Inc. Method and device for producing vaccine
CA2648792C (en) 2006-04-20 2016-06-21 Wyeth Purification processes for isolating purified vesicular stomatitis virus from cell culture
US8778353B2 (en) 2006-05-01 2014-07-15 Technovax, Inc. Influenza virus-like particle (VLP) compositions
US20080286850A1 (en) 2006-09-15 2008-11-20 Medimmune Vaccines, Inc. Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
EP1982727A1 (en) 2007-04-17 2008-10-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for purification of viral proteins
AU2009296701B2 (en) 2008-09-24 2015-02-19 Medimmune, Llc Methods for cultivating cells, propagating and purifying viruses
KR20110074563A (en) 2008-09-24 2011-06-30 메디뮨 엘엘씨 Methods for purification of viruses

Also Published As

Publication number Publication date
CA2663522A1 (en) 2008-09-04
US8357376B2 (en) 2013-01-22
CN103361319A (en) 2013-10-23
EP2615167A1 (en) 2013-07-17
KR20090057444A (en) 2009-06-05
WO2008105931A2 (en) 2008-09-04
JP2010503412A (en) 2010-02-04
EP2069480A2 (en) 2009-06-17
CN101627113A (en) 2010-01-13
AU2007347716A1 (en) 2008-09-04
SG174813A1 (en) 2011-10-28
EP2069480A4 (en) 2011-03-30
RU2012145173A (en) 2014-04-27
US20100112669A1 (en) 2010-05-06
US8846032B2 (en) 2014-09-30
AU2007347716B2 (en) 2013-06-20
WO2008105931A3 (en) 2009-02-19
US20130052717A1 (en) 2013-02-28
MX2009002741A (en) 2009-05-11
CN101627113B (en) 2013-04-24
KR20140075022A (en) 2014-06-18
EP2069480B1 (en) 2014-03-19
RU2487935C2 (en) 2013-07-20
JP2013153762A (en) 2013-08-15
ES2473275T3 (en) 2014-07-04
JP5260525B2 (en) 2013-08-14
US20080286850A1 (en) 2008-11-20
RU2009113671A (en) 2010-10-20
KR101464783B1 (en) 2014-11-26
CA2663522C (en) 2015-06-02
BRPI0716724A2 (en) 2013-10-01

Similar Documents

Publication Publication Date Title
SG10201501780QA (en) Method of purifying influenza virus and removing mdck cell dna contaminants
EP2325449A4 (en) Exhaust gas purification system and exhaust gas purifying method using same
ZA200808666B (en) Method of inducing virus tolerance of plants
BRPI0909324A2 (en) Gas separation system and process
HK1189649A1 (en) An industrial process efficiency method and system
EP2194249A4 (en) Exhaust gas purification system and method
EP2194248A4 (en) Exhaust purification system and exhaust purifying method
SG134262A1 (en) Water purification system and method
GB2445441B (en) Nucleic acid purification method
DE502007006027D1 (en) EXHAUST GAS TREATMENT SYSTEM AND METHOD FOR EXHAUST GAS CLEANING
EP1920054A4 (en) Method for separating and purifying rna
EP2290204A4 (en) Exhaust gas purifier and system for exhaust gas purification
EP1978220A4 (en) Exhaust gas purification method and exhaust gas purification system
EP1913991A4 (en) Purification apparatus and method of purification
PT1949956T (en) Method and installation for purification of fumes containing acid pollutants
EP1978219A4 (en) Exhaust gas purification method and exhaust gas purification system
EP2329567A4 (en) Gas liquid contactor and effluent cleaning system and method
EG26516A (en) Method of purifying apolipoprotein A-1
EP2058283A4 (en) Water purification method and system therefor
EP2343121B8 (en) Exhaust gas purifying catalyst and purification method using same
GB0608190D0 (en) Method of purification
EP2377949A4 (en) Construction method and system of fragments assembling scaffold, and genome sequencing device
SG10201406066WA (en) Melt-crystallization separation and purification process
EP1942078A4 (en) Method for purification of silica particles, purifier, and purified silica particles
EP1853704A4 (en) Method for separating and purifying nucleic acid